Physician
Colorado Permanente Medical Group, P.C.
Colorado Permanente Medical Group, P.C. was paid $23.17M by Medicaid between Jan 2018 and Dec 2024, across 175 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoCOLORADO PERMANENTE MEDICAL GROUP, P.C.
DENVER, CO 80247
DENVER, CO 80247
33aNPI1760599724assigned 08/24/2006
33bProvider typeNeurology Physician
28Total paid$23.17M
24GClaims450,478
24DCodes billed175
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Neurology Physician providers in Colorado
Rank by total paid#1 of 54
Median peer was paid$15K
This provider vs. median1,505×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,079 | $2.37M | |
| 2019 | 46,302 | $3.11M | |
| 2020 | 41,124 | $1.93M | |
| 2021 | 83,094 | $3.27M | |
| 2022 | 68,645 | $3.55M | |
| 2023 | 98,824 | $5.21M | |
| 2024incomplete | 70,410 | $3.72M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 91,323 | 86,330 | $5.67M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 22,025 | 20,066 | $2.59M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.2% | 22,256 | 20,839 | $1.90M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.4% | 27,892 | 26,616 | $1.26M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.4% | 12,477 | 11,544 | $1.01M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3.8% | 10,110 | 9,917 | $887K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.6% | 46,016 | 43,216 | $825K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.2% | 11,821 | 10,777 | $517K |
| 90686 | 2.0% | 36,340 | 35,388 | $467K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.9% | 4,225 | 4,124 | $449K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1.7% | 2,166 | 1,923 | $404K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.6% | 3,195 | 3,109 | $379K |
163 more codes
| 99479 | Subsequent intensive care, per day, very low birth weight infant | 1.5% | 4,231 | $345K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1.5% | 1,485 | $339K |
| 71046 | Radiologic examination, chest; 2 views | 1.4% | 11,847 | $321K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.3% | 3,364 | $300K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.3% | 4,714 | $291K |
| 91320 | 1.2% | 3,573 | $276K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.2% | 1,476 | $274K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1.1% | 1,053 | $248K |
| 99203 | Doctor's office visit, new patient (routine) | 1.0% | 2,585 | $238K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.0% | 2,217 | $232K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,975 | $231K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 634 | $214K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,391 | $210K |
| 99442 | <1% | 3,942 | $200K | |
| 95800 | <1% | 1,670 | $194K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 384 | $168K |
| 0002A | <1% | 5,078 | $168K | |
| 90480 | <1% | 4,511 | $167K | |
| 0001A | <1% | 5,074 | $161K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,712 | $148K |
| 73221 | <1% | 852 | $133K | |
| 72141 | <1% | 492 | $112K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 4,077 | $107K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,794 | $96K |
| 0012A | <1% | 2,487 | $78K | |
| 0011A | <1% | 2,422 | $68K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 96 | $66K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,203 | $65K |
| 90656 | <1% | 5,624 | $65K | |
| 99480 | Subsequent intensive care, per day, low birth weight infant | <1% | 986 | $57K |
| 0124A | <1% | 1,384 | $54K | |
| 0072A | <1% | 1,108 | $54K | |
| 0071A | <1% | 1,171 | $53K | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | <1% | 488 | $53K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 809 | $51K |
| 77080 | <1% | 1,787 | $46K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,958 | $46K |
| 99441 | <1% | 1,556 | $45K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 623 | $42K |
| 76642 | <1% | 774 | $42K | |
| 90461 | <1% | 5,183 | $36K | |
| 90677 | <1% | 724 | $35K | |
| 76830 | Ultrasound, transvaginal | <1% | 472 | $33K |
| 0064A | <1% | 1,073 | $31K | |
| 73630 | <1% | 1,389 | $30K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 510 | $29K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,413 | $28K |
| 0004A | <1% | 852 | $26K | |
| 64615 | <1% | 321 | $26K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 906 | $26K |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | <1% | 132 | $26K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 425 | $24K |
| 71250 | <1% | 244 | $23K | |
| 90670 | <1% | 507 | $23K | |
| 73560 | <1% | 1,205 | $23K | |
| 73565 | <1% | 933 | $20K | |
| 95117 | <1% | 1,631 | $17K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 272 | $16K |
| 92567 | <1% | 1,443 | $16K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 95 | $15K |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 818 | $15K |
| 73610 | <1% | 545 | $13K | |
| 92227 | <1% | 1,564 | $12K | |
| 77066 | Tomosynthesis, mammo | <1% | 107 | $11K |
| 73110 | <1% | 297 | $9K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 157 | $9K |
| 0054A | <1% | 270 | $8K | |
| 73030 | <1% | 397 | $8K | |
| 99460 | <1% | 117 | $8K | |
| 90651 | <1% | 160 | $7K | |
| 77072 | <1% | 322 | $7K | |
| 92557 | <1% | 316 | $7K | |
| 92002 | <1% | 101 | $7K | |
| 71271 | <1% | 59 | $6K | |
| 90648 | <1% | 1,314 | $6K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 154 | $5K |
| 93000 | <1% | 315 | $5K | |
| 92134 | <1% | 270 | $5K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 71 | $4K |
| 72100 | <1% | 141 | $4K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 39 | $4K |
| 81329 | <1% | 75 | $4K | |
| 99404 | <1% | 63 | $4K | |
| 97161 | <1% | 97 | $4K | |
| 99478 | <1% | 31 | $4K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 56 | $4K |
| 73130 | <1% | 140 | $3K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 26 | $3K |
| 99152 | <1% | 109 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 44 | $3K |
| 90723 | <1% | 327 | $3K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 43 | $2K |
| 90662 | <1% | 614 | $2K | |
| 90679 | <1% | 18 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 29 | $2K |
| 77065 | Tomosynthesis, mammo | <1% | 27 | $2K |
| 0031A | <1% | 84 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 45 | $2K |
| 0003A | <1% | 53 | $2K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 30 | $2K |
| 92587 | <1% | 56 | $1K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 13 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 114 | $1K |
| 0134A | <1% | 29 | $1K | |
| 70486 | <1% | 13 | $1K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 16 | $1K |
| 90734 | <1% | 24 | $1K | |
| 73140 | <1% | 39 | $1K | |
| 93971 | <1% | 15 | $1K | |
| 88720 | <1% | 235 | $1K | |
| 72040 | <1% | 43 | $1K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 18 | $998.20 |
| 0052A | <1% | 20 | $967.73 | |
| V2020 | Frames, purchases | <1% | 26 | $927.42 |
| 73502 | <1% | 30 | $854.51 | |
| 97165 | <1% | 16 | $838.70 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 17 | $817.47 |
| 0053A | <1% | 13 | $741.24 | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 13 | $713.08 |
| 90633 | <1% | 51 | $713.00 | |
| 59025 | Fetal non-stress test | <1% | 21 | $650.39 |
| 97162 | <1% | 12 | $583.10 | |
| 96381 | <1% | 25 | $552.57 | |
| 90710 | <1% | 12 | $542.00 | |
| 99422 | <1% | 124 | $534.00 | |
| 11721 | <1% | 28 | $470.57 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 13 | $450.00 |
| 91200 | <1% | 17 | $419.40 | |
| 92015 | Determination of refractive state | <1% | 13 | $403.00 |
| 96040 | <1% | 46 | $386.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 30 | $357.83 |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 51 | $357.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 15 | $343.44 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 38 | $343.12 |
| 20610 | <1% | 13 | $265.25 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 569 | $258.00 |
| 93272 | <1% | 13 | $194.40 | |
| 81025 | <1% | 25 | $192.35 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 163 | $174.01 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 25 | $137.12 |
| 90681 | <1% | 16 | $115.00 | |
| 81002 | <1% | 39 | $112.58 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 16 | $105.60 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 179 | $74.63 |
| 93270 | <1% | 13 | $70.48 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 386 | $64.32 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 30 | $52.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 117 | $43.86 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 14 | $30.24 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 49 | $14.03 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 791 | $0.00 |
| 91301 | 0% | 4,960 | $0.00 | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 0% | 269 | $0.00 |
| 91303 | 0% | 61 | $0.00 | |
| 91307 | 0% | 409 | $0.00 | |
| 91306 | 0% | 345 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 0% | 26 | $0.00 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 0% | 18 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 38 | $0.00 |
| 91300 | 0% | 10,367 | $0.00 | |
| 0502F | 0% | 2,553 | $0.00 | |
| 99421 | 0% | 26 | $0.00 | |
| 98940 | 0% | 74 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSPLINTER, MATTHEW (CPMG CFO)